| Year |
Citation |
Score |
| 2017 |
Banik B, Wen R, Marrache S, Kumar A, Kolishetti N, Howerth EW, Dhar S. Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution. Nanoscale. PMID 29218349 DOI: 10.1039/C7Nr06295H |
0.739 |
|
| 2015 |
Feldhaeusser B, Platt SR, Marrache S, Kolishetti N, Pathak RK, Montgomery DJ, Reno LR, Howerth E, Dhar S. Evaluation of nanoparticle delivered cisplatin in beagles. Nanoscale. 7: 13822-30. PMID 26234400 DOI: 10.1039/C5Nr03447G |
0.736 |
|
| 2015 |
Marrache S, Dhar S. The energy blocker inside the power house: Mitochondria targeted delivery of 3-bromopyruvate. Chemical Science (Royal Society of Chemistry : 2010). 6: 1832-1845. PMID 25709804 DOI: 10.1039/C4Sc01963F |
0.704 |
|
| 2015 |
Marrache S, Tundup S, Harn DA, Dhar S. Ex vivo generation of functional immune cells by mitochondria-targeted photosensitization of cancer cells. Methods in Molecular Biology (Clifton, N.J.). 1265: 113-22. PMID 25634271 DOI: 10.1007/978-1-4939-2288-8_9 |
0.677 |
|
| 2015 |
Marrache S, Pathak RK, Dhar S. Formulation and optimization of mitochondria-targeted polymeric nanoparticles. Methods in Molecular Biology (Clifton, N.J.). 1265: 103-12. PMID 25634270 DOI: 10.1007/978-1-4939-2288-8_8 |
0.741 |
|
| 2015 |
Hung SW, Marrache S, Cummins S, Bhutia YD, Mody H, Hooks SB, Dhar S, Govindarajan R. Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach. Cancer Letters. 359: 233-40. PMID 25600708 DOI: 10.1016/J.Canlet.2015.01.017 |
0.661 |
|
| 2015 |
Feldhaeusser B, Platt SR, Marrache S, Kolishetti N, Pathak RK, Montgomery DJ, Reno LR, Howerth E, Dhar S. Evaluation of nanoparticle delivered cisplatin in beagles Nanoscale. 7: 13822-13830. DOI: 10.1039/c5nr03447g |
0.605 |
|
| 2014 |
Marrache S, Pathak RK, Dhar S. Detouring of cisplatin to access mitochondrial genome for overcoming resistance. Proceedings of the National Academy of Sciences of the United States of America. 111: 10444-9. PMID 25002500 DOI: 10.1073/Pnas.1405244111 |
0.743 |
|
| 2014 |
Pathak RK, Marrache S, Harn DA, Dhar S. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate. Acs Chemical Biology. 9: 1178-87. PMID 24617941 DOI: 10.1021/Cb400944Y |
0.721 |
|
| 2014 |
Pathak RK, Marrache S, Choi JH, Berding TB, Dhar S. The prodrug platin-A: simultaneous release of cisplatin and aspirin. Angewandte Chemie (International Ed. in English). 53: 1963-7. PMID 24453035 DOI: 10.1002/Anie.201308899 |
0.687 |
|
| 2013 |
Marrache S, Dhar S. Reply to Cormode et al.: High-density lipoprotein mimicking synthetic nanoparticle Proceedings of the National Academy of Sciences of the United States of America. 110. PMID 24171202 DOI: 10.1073/Pnas.1311060110 |
0.622 |
|
| 2013 |
Hung SW, Mody H, Marrache S, Bhutia YD, Davis F, Cho JH, Zastre J, Dhar S, Chu CK, Govindarajan R. Pharmacological reversal of histone methylation presensitizes pancreatic cancer cells to nucleoside drugs: in vitro optimization and novel nanoparticle delivery studies. Plos One. 8: e71196. PMID 23940717 DOI: 10.1371/Journal.Pone.0071196 |
0.667 |
|
| 2013 |
Marrache S, Tundup S, Harn DA, Dhar S. Ex vivo programming of dendritic cells by mitochondria-targeted nanoparticles to produce interferon-gamma for cancer immunotherapy. Acs Nano. 7: 7392-402. PMID 23899410 DOI: 10.1021/Nn403158N |
0.705 |
|
| 2013 |
Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases. Current Medicinal Chemistry. 20: 3500-14. PMID 23834187 DOI: 10.2174/0929867311320280007 |
0.736 |
|
| 2013 |
Marrache S, Dhar S. Biodegradable synthetic high-density lipoprotein nanoparticles for atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 110: 9445-50. PMID 23671083 DOI: 10.1073/Pnas.1301929110 |
0.685 |
|
| 2013 |
Marrache S, Choi JH, Tundup S, Zaver D, Harn DA, Dhar S. Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer. Integrative Biology : Quantitative Biosciences From Nano to Macro. 5: 215-23. PMID 22832596 DOI: 10.1039/C2Ib20125A |
0.709 |
|
| 2013 |
Marrache S, Pathak RK, Darley KL, Choi JH, Zaver D, Kolishetti N, Dhar S. Nanocarriers for tracking and treating diseases Current Medicinal Chemistry. 20: 3500-3514. DOI: 10.2174/0929867311320280007 |
0.655 |
|
| 2013 |
Hung SW, Mody H, Marrache S, Bhutia YD, Davis F, Cho JH, Dhar S, Chu CK, Govindarajan R. Abstract 1025: Optimized DZNep exposure presensitizes pancreatic cancer cells to anticancer nucleoside analogues: potential clinical implications. Cancer Research. 73: 1025-1025. DOI: 10.1158/1538-7445.Am2013-1025 |
0.658 |
|
| 2012 |
Marrache S, Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proceedings of the National Academy of Sciences of the United States of America. 109: 16288-93. PMID 22991470 DOI: 10.1073/Pnas.1210096109 |
0.713 |
|
| Show low-probability matches. |